Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by grosdavidon Apr 15, 2020 11:59am
160 Views
Post# 30912002

It’s hard to predict how the market

It’s hard to predict how the market

Can react and what a trading session will look like.

But one this is for sure, the facts are present and this may be just the start of something good. So many possibilities for AGN.

-CEO having alot of public appearences
-AGN being named on a couple of popular sites
-AGN having a positive relationship with HC and FDA at the moment

The next steps could be grants from Gov bodies.
This is an assumption, but the facts are that AGN has shown and proven to hold something that could solve a big portion of the problem. 


Imagine a world today knowing that a simple capsule could diminish the symptoms of COVID, and therefore cutting its duration, and basically turning it into an innocent flu.

Now imagine, that have COVID for the first time, then with this drug, could diminish the chance of X% of catching it again. That is what they will try to prove right now. This could be a game changer.

Bullboard Posts